Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
1d
What's Next For Johnson & Johnson Stock?
Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.
1d
Johnson & Johnson Q3 Earnings Review: Nicely Poised For Steady Growth (Upgrade)
Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...
2d
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Judge unseals new evidence
Preliminary cause of death
School shooting report
La Nina could arrive soon
Bladder cancer drug pulled
PG&E shuts off power
Republicans appeal ruling
Three Americans detained
Fire prompts evacuations
OK classroom Bible suit
NYC giant pigeon sculpture
Ex-MN congressman dies
School shooting indictment
NC breaks turnout record
Calif. oil refinery closure
988 Lifeline georouting
Eases voting rules
Emergency abortion ruling
Teen tobacco use falls
To furlough 700 workers
‘Full Self-Driving’ probe
US charges ex-Indian spy
Lebanese citizens get TPS
Dow closes at record high
Space export curbs eased
Sells for $9M at auction
Musk's first Trump event
NK sending troops to RU?
At decade-high level
Nevada US Senate debate
$4M LAPD fentanyl seizure
Related topics
Q3
Republican Party
Medtech
Pittsburgh Pirates
Springfield
Feedback